SRT3 Stock Financial Analysis - Sartorius Aktiengesellschaft

Overview

Sartorius Aktiengesellschaft, headquartered in Göttingen, Germany, operates primarily in the biotechnology sector, providing essential products and services for biopharmaceutical research and manufacturing. The company plays a critical role in the development and production of biopharmaceuticals, focusing on highly innovative technologies and solutions that facilitate the efficient manufacture of therapies. Key projects include advanced bioprocess solutions that integrate digital monitoring and analytics to enhance the scalability and productivity of drug manufacturing. Sartorius also actively expands its capabilities through strategic acquisitions, further strengthening its offering in bioanalytics and lab products, critical to both research institutions and the pharmaceutical industry. This strategic direction not only underscores its commitment to supporting the fast-paced growth of the biopharma sector but also enhances its global footprint in essential healthcare innovation.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is 3,467.70 MM.
The operating income for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is 474.90 MM.
The net income for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is 104.10 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	3,467.70	474.90	104.10
2025-03-31	3,444.10	449.50	95.60
2024-12-31	3,380.70	434.70	84.00
2024-09-30	3,323.70	443.30	77.60
2024-06-30	3,340.80	466.90	78.40
2024-03-31	3,312.10	485.90	149.40
2023-12-31	3,395.70	541.70	205.60
2023-09-30	3,607.70	744.00	358.30
2023-06-30	3,849.60	924.50	494.70
2023-03-31	4,053.10	1,075.10	565.50
2022-12-31	4,174.70	1,175.40	678.10
2022-09-30	4,035.20	1,083.50	534.00
2022-06-30	3,880.30	1,050.40	489.00
2022-03-31	3,682.90	1,005.80	434.30
2021-12-31	3,449.20	932.90	318.90
2021-09-30	3,182.56	860.93	371.89
2021-06-30	2,908.06	761.93	331.69
2021-03-31	2,616.86	613.73	254.19
2020-12-31	2,335.66	510.73	210.09
2020-09-30	2,151.17	438.99	181.39

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31	1.22	1.22
2024-09-30
2024-06-30	1.13	1.13
2024-03-31
2023-12-31	3.01	3.01
2023-09-30
2023-06-30
2023-03-31
2022-12-31	9.91	9.91
2022-09-30	7.81	7.81
2022-06-30
2022-03-31
2021-12-31	4.66	4.66
2021-09-30
2021-06-30
2021-03-31
2020-12-31	3.07	3.07
2020-09-30

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is 918.80 MM.
The cash from investing activities for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is -354.40 MM.
The cash from financing activities for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is -344.00 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	918.80	-354.40	-344.00
2025-03-31	1,070.00	-368.50	-975.20
2024-12-31	976.20	-425.80	-128.30
2024-09-30	924.00	-463.80	-191.70
2024-06-30	837.80	-2,735.60	2,318.30
2024-03-31	696.60	-2,821.30	3,057.50
2023-12-31	853.60	-2,823.30	2,165.70
2023-09-30	821.20	-2,923.40	2,166.90
2023-06-30	806.60	-1,162.00	278.20
2023-03-31	743.70	-1,103.00	256.30
2022-12-31	734.20	-1,129.90	209.90
2022-09-30	690.20	-1,072.50	236.80
2022-06-30	722.70	-704.10	-228.80
2022-03-31	837.20	-643.40	-314.80
2021-12-31	873.20	-569.60	-172.60
2021-09-30	770.02	-755.04	-134.13
2021-06-30	736.83	-581.04	76.67
2021-03-31	626.52	-1,314.84	922.07
2020-12-31	511.52	-1,270.54	907.47
2020-09-30	503.09	-1,004.08	910.45

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Management Effectiveness

The roa for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is 0.01.
The roe for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is 0.03.
The roic for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is 0.01.
The croic for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is -0.03.
The ocroic for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is 0.13.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.01	0.03	0.01	-0.03	0.13
2025-03-31	0.01	0.03	0.01	0.05	0.12
2024-12-31	0.01	0.03	0.01	0.03	0.11
2024-09-30	0.01	0.03	0.02	0.11	0.08
2024-06-30	0.02	0.06	0.02	0.11	0.08
2024-03-31	0.03	0.08	0.03	0.03	0.11
2023-12-31	0.05	0.14	0.04	0.01	0.10
2023-09-30	0.08	0.22	0.09	-0.01	0.15
2023-06-30	0.08	0.22	0.09	-0.01	0.15
2023-03-31	0.10	0.29	0.11	-0.02	0.14
2022-12-31	0.09	0.31	0.11	-0.02	0.13
2022-09-30	0.09	0.31	0.11	-0.02	0.13
2022-06-30	0.09	0.30	0.11	-0.04	0.16
2022-03-31	0.09	0.31	0.11	-0.03	0.21
2021-12-31	0.07	0.23	0.08	0.04	0.23
2021-09-30	0.09	0.31	0.10	-0.03	0.20
2021-06-30	0.09	0.29	0.09	0.06	0.20
2021-03-31	0.09	0.22	0.07	0.07	0.18
2020-12-31	0.08	0.21	0.06	0.04	0.15
2020-09-30	0.06	0.17	0.06	0.12	0.15

Gross Margins

The gross margin for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is 0.45.
The net margin for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is 0.03.
The operating margin for Sartorius Aktiengesellschaft - Preferred Stock as of 30 June 2025 is 0.13.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.45	0.03	0.13
2025-03-31	0.45	0.02	0.12
2024-12-31	0.45	0.02	0.13
2024-09-30	0.46	0.04	0.15
2024-06-30	0.46	0.04	0.15
2024-03-31	0.46	0.06	0.16
2023-12-31	0.50	0.10	0.20
2023-09-30	0.52	0.13	0.24
2023-06-30	0.52	0.13	0.24
2023-03-31	0.52	0.14	0.27
2022-12-31	0.52	0.13	0.27
2022-09-30	0.52	0.13	0.27
2022-06-30	0.52	0.13	0.27
2022-03-31	0.53	0.12	0.27
2021-12-31	0.53	0.09	0.27
2021-09-30	0.53	0.12	0.27
2021-06-30	0.53	0.12	0.26
2021-03-31	0.52	0.10	0.23
2020-12-31	0.52	0.10	0.22
2020-09-30	0.52	0.09	0.21

DE:SRT3	€ 194,25
GB:SRT3D
IT:1SRT3	€ 203,20
GB:0NIR	€ 190,90
US:SUVPF
BG:SRT3

SRT3 Stock Financial Analysis - Sartorius Aktiengesellschaft - Preferred Stock (WBAG) Stock